Evaluating metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli

F Silva, JA Queiroz, FC Domingues - Biotechnology advances, 2012 - Elsevier
In the context of recombinant DNA technology, the development of feasible and high-
yielding plasmid DNA production processes has regained attention as more evidence for its …

Advances in chromatographic supports for pharmaceutical‐grade plasmid DNA purification

 Sousa, F Sousa, JA Queiroz - Journal of separation science, 2012 - Wiley Online Library
Chromatographic technology is undoubtedly one of the most diverse and powerful
purification methods for downstream process applications. The diversity and quantity of …

Enhancing E. coli Tolerance towards Oxidative Stress via Engineering Its Global Regulator cAMP Receptor Protein (CRP)

S Basak, R Jiang - PloS one, 2012 - journals.plos.org
Oxidative damage to microbial hosts often occurs under stressful conditions during
bioprocessing. Classical strain engineering approaches are usually both time-consuming …

Bacterial RNA extraction and purification from whole human blood using isotachophoresis

A Rogacs, Y Qu, JG Santiago - Analytical chemistry, 2012 - ACS Publications
We demonstrate a novel assay for physicochemical extraction and isotachophoresis-based
purification of 16S rRNA from whole human blood infected with Pseudomonas putida. This …

[图书][B] Plasmid biopharmaceuticals: basics, applications, and manufacturing

DMF Prazeres - 2011 - books.google.com
The book addresses the basics, applications, and manufacturing of plasmid
biopharmaceuticals. The survey of the most relevant characteristics of plasmids provides the …

Targeted gene therapy for the treatment of heart failure

K Rapti, AH Chaanine, RJ Hajjar - Canadian Journal of Cardiology, 2011 - Elsevier
Chronic heart failure is one of the leading causes of morbidity and mortality in Western
countries and is a major financial burden to the health care system. Pharmacologic …

Development of a non-viral gene delivery vector based on the dynein light chain Rp3 and the TAT peptide

MTP Favaro, MAS de Toledo, RF Alves… - Journal of …, 2014 - Elsevier
Gene therapy and DNA vaccination trials are limited by the lack of gene delivery vectors that
combine efficiency and safety. Hence, the development of modular recombinant proteins …

Development of a recombinant fusion protein based on the dynein light chain LC8 for non-viral gene delivery

MAS Toledo, R Janissen, MTP Favaro, MA Cotta… - Journal of controlled …, 2012 - Elsevier
The low efficiency of gene transfer is a recurrent problem in DNA vaccine development and
gene therapy studies using non-viral vectors such as plasmid DNA (pDNA). This is mainly …

Enhanced biosynthesis of plasmid DNA from Escherichia coli VH33 using Box–Behnken design associated to aromatic amino acids pathway

LM Martins, AQ Pedro, D Oppolzer, F Sousa… - Biochemical …, 2015 - Elsevier
Therapeutic applications of plasmid DNA have significantly advanced during the last years
and future demand for plasmid DNA requires the development of efficient bioprocesses …

Recombinant protein-based nanocarriers and their association with cationic liposomes: characterization and in vitro evaluation

RF Alves, MTP Favaro, TA Balbino… - Colloids and Surfaces A …, 2017 - Elsevier
A major bottleneck in the development of efficient protocols for gene therapy and DNA
vaccination is the low efficiency of gene transfer by non-viral vectors. This is mainly …